TAGWORKS
LIVE

Serial Number

90873410

Owner

Tagworks Pharmaceuticals BV

Attorney

Michael Fedrick

Filing Date

Aug 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TAGWORKS Trademark

Serial Number: 90873410 • Registration: 7265620

TAGWORKS is a trademark filed by Tagworks Pharmaceuticals BV on August 9, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Tagworks Pharmaceuticals BV

c/o Radboud UMC, Dept. Nucl. Med. & Rad.
Nijmegen 6525GA , NL

Entity Type: 99

Trademark Details

Filing Date

August 9, 2021

Registration Date

January 9, 2024

Published for Opposition

November 8, 2022

Goods & Services

pharmaceutical and veterinary preparations, namely, T-cell engaging biologics or drug conjugates based on biologics for therapy, biologics for immunoimaging, immunotherapy; pharmaceutical and veterinary preparations, namely, antibodies, antibody fragments, peptides or small molecules for immunotherapy treatment; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, or antibodies modified with a chemical tag or a radiolabeled chemical tag, for nuclear imaging or therapy; pharmaceutical preparations for treatment or prevention of cancer, autoimmune or infectious disease; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease; sanitary preparations for medical purposes; biopharmaceutical preparations for use in human and veterinary medicine for treatment of cancer, autoimmune diseases and infectious diseases; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemicals and biological substances for medical use, namely, diagnostic reagents; pharmaceutical and veterinary preparations, namely, immune cell engaging biologics, preparations for imaging, prodrugs, or drug conjugates based on biologics for therapy, biologics, peptides or small molecules for radiotherapy, immunotherapy or chemotherapy; pharmaceutical and veterinary nanoparticles, namely, polymers, liposomes, biologics, peptides, or small molecules modified with a chemical tag or linker or a radiolabelled chemical tag, for nuclear imaging or therapy; pharmaceutical and chemical preparations for medical purposes, namely, chemical probes or chemical tags or linkers conjugated to biologics for the treatment of cancer, autoimmune disease, or infectious disease

chemical preparations for use in industry and science; chemical preparations and kits comprised of chemical preparations, for use in modifying or isolating biological materials; chemical preparations for solid phase chemistry or separation technology, such as coated polymers, in bead or resin form, for use in manufacturing

scientific and technological research in the field of immunoimaging and immunotherapy to provide T-cell engaging biologics or preparations for imaging or drug conjugates based on antibodies, antibody fragments, peptides, nanoparticle polymers or nanoparticle liposomes, or radiolabeled antibodies for nuclear imaging or therapy, or to provide preparations for medical diagnostics; scientific and technological research, in the field of imaging or immunotherapy to provide immune-cell engaging biologics or preparations for imaging or drug conjugates based on biologics for therapy, namely, antibodies, antibody fragments, peptides, or small molecules, nanoparticle polymers or nanoparticle liposomes, or radiolabelled antibodies, biologics, peptides and small molecules for nuclear imaging or therapy, or to provide preparations for medical diagnostics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Dec 4, 2023 DP1B
CORRECTED NOA E-MAILED
Sep 19, 2023 NOAC
NOTICE OF ALLOWANCE CORRECTION ENTERED
Sep 18, 2023 ICNA
NOTICE OF ALLOWANCE CANCELLED
Aug 23, 2023 IUCN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 23, 2023 EPPA
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 10, 2023 AITU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2023 EXRA
AMENDMENT AFTER NOA NOT ENTERED
Jun 16, 2023 INOA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 16, 2023 EPPA
SOU EXTENSION 1 GRANTED
Jun 16, 2023 EX1G
SOU EXTENSION 1 FILED
Jun 16, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 16, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 8, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 19, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 6, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 6, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 6, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 6, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2022 CNRT
ASSIGNED TO EXAMINER
May 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2021 NWOS
NEW APPLICATION ENTERED
Aug 12, 2021 NWAP